课题基金 / 基金详情

application of ganglioside GM3 and glycosyltransforase for bladder cancer treatment

application of ganglioside GM3 and glycosyltransforase for bladder cancer treatment
神经节苷脂GM3联合糖基转移酶在膀胱癌治疗中的应用
批准号:
05671295
负责人:
CHIBA Yutaka
金额:
$1.34万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1993
资助国家:
日本
项目状态:
已结题
起止时间:
1993 至 1995

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
1.Glycolipid expression chages in human bladder tumorMassive GM3 accumulation in papillary, superficial tumor was the most conspicuous change against invasive tumors. The in vitro invasion activity of human transitional cell carcinoma, T-24 and KK47 were both inhibited by exogeneously added GM3 at the concentration of 10-100mug/ml.2.Glycosyltransferase activity in human bladder tumor sample.The altered activities of Gb3, GM3, GD3 synthetases were consistent with GM3 accumulation in supericial tumors.3.Glycolipid expression changes in BBN induced rat bladder tumor.We emphasized the importance of standardization of the BBN induced rat bladder tumor by endoscopic observation. The glycolipid expression changes during tumor development remained unknown.4.Brefeldin A altered ganglioside expression pattern in human bladder tumor cells and inhibits their in vitro invasion activity.T24, YTS-1, KK47, YTS-3 and HCV-29 were assessed about their alteration in ganglioside composition, growth activity and invasion activity affected by Brefeldin A administration. Brefeldin A reduced sialylLe^x expression and increased GM3 expression. Brefeldin A inhibited the invasion activities of the cells at a low concentration.5.Anti-tumor effect of locally administered GM3 on mouse MBT-2 tumor.Locally injected GM3 inhibited invasion and growth of the subcutaneously inoculated MBT-2 at the concentration of 10 and 100mug/ml. The C-DNA of alpha2,3 sialyltransferase that synthesize GM3 has not yet been cloned. Thus, it remained impossible to control the invasion activity through the altered tumor cell phenotype by alpha2,3 sialyltransferase transfection.
期刊论文(17)
专著(0)
科研奖励(0)
会议论文
大山 力: "精巣腫瘍におけるPLNAとAgNORの臨床的意義" 日泌尿会誌. 86. 1543-1551 (1995)
Tsutomu Oyama:“PLNA 和 AgNOR 在睾丸癌中的临床意义”日本泌尿学会杂志 86. 1543-1551 (1995)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Ohyama C.: "GM3 inhibits murinl MBT-2 tumor in vasion and growth" Int.J.Oncol(in press). (1996)
Ohyama C.:“GM3 抑制鼠 MBT-2 肿瘤的血管扩张和生长”Int.J.Oncol(出版中)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
大山力: "精巣腫瘍におけるPCNAとAgNORの臨床的意義" 日泌尿会誌. 86. 1543-1551 (1995)
Tsutomu Oyama:“PCNA 和 AgNOR 在睾丸癌中的临床意义”日本泌尿外科学会杂志 86. 1543-1551 (1995)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
大山 力: "マウスMBT-2細胞に対するGM3局注の抗腫瘍効果" 第53回日本癌学会総会記事. 376 (1994)
Tsutomu Oyama:“局部注射 GM3 对小鼠 MBT-2 细胞的抗肿瘤作用”,日本癌症协会第 53 届年会文章 376 (1994)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
12
    国内基金
    海外基金
    Ganglioside-CD44信号通路在PEMFs对小鼠缺血心肌血管生成影响中的作用及其机制研究
    • 批准号:
      81572231
    • 项目类别:
      面上项目
    • 资助金额:
      57.0万元
    • 批准年份:
      2015
    • 负责人:
      魏全
    • 依托单位: